Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 1,984.60
+24.10 (1.23%)
Jul 29, 2025, 3:30 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 906.35 billion as of July 29, 2025. Its market cap has increased by 8.81% in one year.
Market Cap
906.35B
Enterprise Value
931.83B
Revenue
227.08B
Ranking
n/a
PE Ratio
27.62
Stock Price
1,984.60
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 906.35B, an increase of 90,703.71%. That is a compound annual growth rate of 30.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 895.43B | -16.52% |
| Dec 31, 2024 | 1,072.58B | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | 442.95B | 27.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,076.47B |
| Divi's Laboratories | 1,756.47B |
| Cipla | 1,237.88B |
| Mankind Pharma | 1,074.50B |
| Apollo Hospitals Enterprise | 1,073.86B |
| Zydus Lifesciences | 982.49B |
| Aurobindo Pharma | 652.12B |
| Fortis Healthcare | 638.35B |